In addition to advancing our own pipeline, Mersana is advancing the development of novel ADC therapies for patients in dire need of better treatments through strategic collaborations with leading pharmaceutical and biotech companies.

Our most recent collaborations include those with Janssen, GSK and Merck KGaA, Darmstadt, Germany.

If you’d like to learn more about partnering opportunities, please contact us at info@mersana.com.